Allergic reactions to Pfizer, Moderna COVID-19 vaccines focus of new clinical trial
Fox News
The National Institutes of Health (NIH) has launched a clinical trial to better understand allergic reactions related to the Moderna and Pfizer- BioNTech COVID-19 vaccines.
The Centers for Disease Control and Prevention (CDC) first reported on the instances of anaphylaxis weeks after the initial rollout of the COVID-19 vaccines. In rare cases, some recipients experienced adverse reactions such as severe allergic reactions within minutes of the vaccine being administered. As such, the agency issued guidance recommending that those who experienced anaphylaxis after the first dose not get the second, and that vaccine providers be equipped with epinephrine, antihistamines, blood pressure monitors and timing devices to check a patient’s pulse.More Related News